Enwei Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 393.34 million compared to CNY 332.83 million a year ago. Revenue was CNY 395.25 million compared to CNY 334.78 million a year ago.

Net income was CNY 63.96 million compared to CNY 39.19 million a year ago. Basic earnings per share from continuing operations was CNY 0.9119 compared to CNY 0.745 a year ago. Diluted earnings per share from continuing operations was CNY 0.9119 compared to CNY 0.745 a year ago.